Envision Healthcare Corporation (EVHC) Stake Lowered by UBS Asset Management Americas Inc.

UBS Asset Management Americas Inc. cut its stake in Envision Healthcare Corporation (NYSE:EVHC) by 13.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 439,904 shares of the company’s stock after selling 71,053 shares during the period. UBS Asset Management Americas Inc. owned 0.38% of Envision Healthcare Corporation worth $26,975,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Russell Investments Group Ltd. purchased a new position in shares of Envision Healthcare Corporation during the fourth quarter valued at about $2,527,000. ING Groep NV acquired a new stake in shares of Envision Healthcare Corporation during the fourth quarter worth approximately $434,000. Aberdeen Asset Management PLC UK acquired a new stake in shares of Envision Healthcare Corporation during the fourth quarter worth approximately $1,270,000. Oxford Asset Management acquired a new stake in shares of Envision Healthcare Corporation during the fourth quarter worth approximately $770,000. Finally, Elkfork Partners LLC acquired a new stake in shares of Envision Healthcare Corporation during the fourth quarter worth approximately $192,000. Hedge funds and other institutional investors own 67.47% of the company’s stock.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Envision Healthcare Corporation (NYSE EVHC) opened at 58.63 on Friday. The firm’s 50-day moving average price is $56.31 and its 200 day moving average price is $63.22. Envision Healthcare Corporation has a 12 month low of $53.12 and a 12 month high of $81.26. The stock’s market cap is $6.81 billion.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, May 2nd. The company reported $0.69 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.69. Envision Healthcare Corporation had a positive return on equity of 5.75% and a negative net margin of 9.16%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $2.52 billion. On average, analysts anticipate that Envision Healthcare Corporation will post $1.40 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by WKRB News and is owned by of WKRB News. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.wkrb13.com/markets/2229706/envision-healthcare-corporation-evhc-stake-lowered-by-ubs-asset-management-americas-inc.html.

EVHC has been the subject of a number of research analyst reports. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $72.00 price target on shares of Envision Healthcare Corporation in a research note on Monday, June 5th. Zacks Investment Research lowered Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, March 7th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $71.00 price target (down previously from $75.00) on shares of Envision Healthcare Corporation in a research note on Wednesday, May 3rd. Barclays PLC reaffirmed an “overweight” rating on shares of Envision Healthcare Corporation in a research note on Tuesday, March 21st. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $80.00 price target on shares of Envision Healthcare Corporation in a research note on Thursday, April 6th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $72.00.

In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Wednesday, May 3rd. The stock was sold at an average price of $60.53, for a total transaction of $90,795.00. Following the transaction, the insider now owns 114,363 shares of the company’s stock, valued at approximately $6,922,392.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.10% of the stock is currently owned by corporate insiders.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229706/envision-healthcare-corporation-evhc-stake-lowered-by-ubs-asset-management-americas-inc.html

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.